这是一篇来自已证抗体库的有关人类 MRP2的综述,是根据29篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合MRP2 抗体。
MRP2 同义词: ABC30; CMOAT; DJS; MRP2; cMRP

艾博抗(上海)贸易有限公司
小鼠 单克隆(M2 III-6)
  • 免疫细胞化学; 人类; 1:200; 图 6s1d
艾博抗(上海)贸易有限公司 MRP2抗体(Abcam, ab3373)被用于被用于免疫细胞化学在人类样本上浓度为1:200 (图 6s1d). elife (2019) ncbi
domestic rabbit 多克隆
  • 免疫组化-冰冻切片; brown rat; 1:100; 图 2c
  • 免疫印迹; brown rat; 1:100; 图 2b
艾博抗(上海)贸易有限公司 MRP2抗体(Abcam, ab203397)被用于被用于免疫组化-冰冻切片在brown rat样本上浓度为1:100 (图 2c) 和 被用于免疫印迹在brown rat样本上浓度为1:100 (图 2b). Exp Ther Med (2016) ncbi
小鼠 单克隆(M2 III-6)
  • 免疫细胞化学; 人类; 图 1a
艾博抗(上海)贸易有限公司 MRP2抗体(Abcam, ab3373)被用于被用于免疫细胞化学在人类样本上 (图 1a). Alcohol Clin Exp Res (2016) ncbi
小鼠 单克隆(M2 III-6)
  • 免疫组化; 人类; 1:200; 图 2a
艾博抗(上海)贸易有限公司 MRP2抗体(Abcam, 3373)被用于被用于免疫组化在人类样本上浓度为1:200 (图 2a). Sci Rep (2016) ncbi
小鼠 单克隆(M2 III-6)
  • 免疫细胞化学; 人类; 1:100; 图 2
艾博抗(上海)贸易有限公司 MRP2抗体(Abcam, ab3373)被用于被用于免疫细胞化学在人类样本上浓度为1:100 (图 2). Sci Rep (2016) ncbi
小鼠 单克隆(M2 III-6)
  • 免疫印迹; 人类; 1:100; 图 3
艾博抗(上海)贸易有限公司 MRP2抗体(Abcam, ab3373)被用于被用于免疫印迹在人类样本上浓度为1:100 (图 3). Exp Ther Med (2015) ncbi
小鼠 单克隆(M2 III-6)
  • 流式细胞仪; 人类; 1:20; 图 1b
艾博抗(上海)贸易有限公司 MRP2抗体(Abcam, M2III-6)被用于被用于流式细胞仪在人类样本上浓度为1:20 (图 1b). Curr Cancer Drug Targets (2016) ncbi
小鼠 单克隆(M2 III-6)
  • 免疫细胞化学; 人类; 1:50; 图 4a
艾博抗(上海)贸易有限公司 MRP2抗体(abcam, ab3373)被用于被用于免疫细胞化学在人类样本上浓度为1:50 (图 4a). Sci Rep (2015) ncbi
小鼠 单克隆(M2 III-6)
  • 免疫印迹; 小鼠; 图 s1
  • 免疫印迹; 人类; 1:100; 图 s1
艾博抗(上海)贸易有限公司 MRP2抗体(Abcam, ab3373)被用于被用于免疫印迹在小鼠样本上 (图 s1) 和 被用于免疫印迹在人类样本上浓度为1:100 (图 s1). PLoS ONE (2015) ncbi
小鼠 单克隆(M2 III-6)
  • 免疫组化-冰冻切片; 人类; 1:50; 图 2
艾博抗(上海)贸易有限公司 MRP2抗体(Abcam, M2III-6)被用于被用于免疫组化-冰冻切片在人类样本上浓度为1:50 (图 2). Pathol Oncol Res (2014) ncbi
小鼠 单克隆(M2 III-6)
  • 免疫印迹; 人类
艾博抗(上海)贸易有限公司 MRP2抗体(Abcam, ab3373)被用于被用于免疫印迹在人类样本上. Biochim Biophys Acta (2014) ncbi
小鼠 单克隆(M2 III-6)
  • 免疫组化-石蜡切片; 人类
艾博抗(上海)贸易有限公司 MRP2抗体(Abcam, AB3373)被用于被用于免疫组化-石蜡切片在人类样本上. Arch Toxicol (2014) ncbi
小鼠 单克隆(M2 III-6)
  • 免疫细胞化学; 人类; 1:100
艾博抗(上海)贸易有限公司 MRP2抗体(Abcam, ab3373)被用于被用于免疫细胞化学在人类样本上浓度为1:100. PLoS ONE (2014) ncbi
Enzo Life Sciences
小鼠 单克隆(M2I-4)
  • 免疫细胞化学; 人类; 图 3a
Enzo Life Sciences MRP2抗体(Alexis Biochemicals, M2-I-4)被用于被用于免疫细胞化学在人类样本上 (图 3a). Hepatology (2017) ncbi
小鼠 单克隆(M2III-6)
  • 免疫印迹; 人类; 图 7a
Enzo Life Sciences MRP2抗体(Enzo Life Sciences, M2III-6)被用于被用于免疫印迹在人类样本上 (图 7a). Toxicology (2016) ncbi
小鼠 单克隆(M2I-4)
  • 免疫组化-冰冻切片; 人类; 1:25; 图 6
Enzo Life Sciences MRP2抗体(Enzo Life Sciences, ALX-801-015-C250)被用于被用于免疫组化-冰冻切片在人类样本上浓度为1:25 (图 6). Sci Rep (2016) ncbi
小鼠 单克隆(M2I-4)
  • 免疫印迹; 人类; 图 2b
Enzo Life Sciences MRP2抗体(Enzo, ALX-801-015)被用于被用于免疫印迹在人类样本上 (图 2b). Drug Metab Dispos (2016) ncbi
小鼠 单克隆(M2III-6)
  • 免疫印迹; 人类
Enzo Life Sciences MRP2抗体(Enzo Life Sciences, M2III-6)被用于被用于免疫印迹在人类样本上. Pharm Res (2015) ncbi
小鼠 单克隆(M2III-6)
  • 免疫印迹; brown rat
Enzo Life Sciences MRP2抗体(Alexis Biochemicals, M2III- 6)被用于被用于免疫印迹在brown rat样本上. Arch Toxicol (2016) ncbi
小鼠 单克隆(M2III-6)
  • 免疫印迹; 人类; 图 1
Enzo Life Sciences MRP2抗体(Enzo Life Sciences, M2III-6)被用于被用于免疫印迹在人类样本上 (图 1). PLoS ONE (2015) ncbi
小鼠 单克隆(M2III-5)
  • 免疫印迹; 人类
Enzo Life Sciences MRP2抗体(Alexis, ALX 801-037)被用于被用于免疫印迹在人类样本上. Toxicol Appl Pharmacol (2015) ncbi
小鼠 单克隆(M2III-5)
  • 免疫印迹; 小鼠
Enzo Life Sciences MRP2抗体(Enzo Life Sciences, M2III-5)被用于被用于免疫印迹在小鼠样本上. Pharm Res (2013) ncbi
小鼠 单克隆(M2III-6)
  • 免疫印迹; 人类
Enzo Life Sciences MRP2抗体(Enzo Life Sciences, M2III-6)被用于被用于免疫印迹在人类样本上. PLoS Negl Trop Dis (2012) ncbi
小鼠 单克隆(M2III-5)
  • 免疫印迹; brown rat
Enzo Life Sciences MRP2抗体(Alexis Axxora, M2III5)被用于被用于免疫印迹在brown rat样本上. Biochem Pharmacol (2012) ncbi
小鼠 单克隆(M2III-6)
  • 免疫细胞化学; brown rat
  • 免疫印迹; brown rat
Enzo Life Sciences MRP2抗体(Alexis Axxora, M2III6)被用于被用于免疫细胞化学在brown rat样本上 和 被用于免疫印迹在brown rat样本上. Biochem Pharmacol (2012) ncbi
小鼠 单克隆(M2III-6)
  • 免疫细胞化学; brown rat
  • 免疫印迹; brown rat
Enzo Life Sciences MRP2抗体(Enzo Life Sciences, M2III-6)被用于被用于免疫细胞化学在brown rat样本上 和 被用于免疫印迹在brown rat样本上. Drug Metab Dispos (2011) ncbi
小鼠 单克隆(M2III-6)
  • 免疫印迹; 人类; 1:500
Enzo Life Sciences MRP2抗体(Alexis, M2III-6)被用于被用于免疫印迹在人类样本上浓度为1:500. Mol Pharmacol (2011) ncbi
赛默飞世尔
小鼠 单克隆(M2 III-6)
  • 免疫细胞化学; 人类; 图 s1c
赛默飞世尔 MRP2抗体(Thermo Fisher Scientific, MA1-26536)被用于被用于免疫细胞化学在人类样本上 (图 s1c). PLoS ONE (2016) ncbi
默克密理博中国
小鼠 单克隆(M2 I-4)
  • 免疫印迹; 人类
默克密理博中国 MRP2抗体(Millipore, MAB4148)被用于被用于免疫印迹在人类样本上. Toxicol Lett (2013) ncbi
小鼠 单克隆(M2 III-6)
  • 免疫印迹; 人类; 1:50
默克密理博中国 MRP2抗体(Millipore Bioscience, M2 III-6)被用于被用于免疫印迹在人类样本上浓度为1:50. Drug Metab Dispos (2011) ncbi
文章列表
  1. Katsuda T, Matsuzaki J, Yamaguchi T, Yamada Y, Prieto Vila M, Hosaka K, et al. Generation of human hepatic progenitor cells with regenerative and metabolic capacities from primary hepatocytes. elife. 2019;8: pubmed 出版商
  2. Sun X, Duan Z, Liu Z, Tang S, Li Y, He S, et al. Inhibition of P-glycoprotein, multidrug resistance-associated protein 2 and cytochrome P450 3A4 improves the oral absorption of octreotide in rats with portal hypertension. Exp Ther Med. 2016;12:3716-3722 pubmed 出版商
  3. Delaunay J, Bruneau A, Hoffmann B, Durand Schneider A, Barbu V, Jacquemin E, et al. Functional defect of variants in the adenosine triphosphate-binding sites of ABCB4 and their rescue by the cystic fibrosis transmembrane conductance regulator potentiator, ivacaftor (VX-770). Hepatology. 2017;65:560-570 pubmed 出版商
  4. Casey C, Bhat G, Holzapfel M, Petrosyan A. Study of Ethanol-Induced Golgi Disorganization Reveals the Potential Mechanism of Alcohol-Impaired N-Glycosylation. Alcohol Clin Exp Res. 2016;40:2573-2590 pubmed 出版商
  5. Sayyed K, Vee M, Abdel Razzak Z, Jouan E, Stieger B, Denizot C, et al. Alteration of human hepatic drug transporter activity and expression by cigarette smoke condensate. Toxicology. 2016;363-364:58-71 pubmed 出版商
  6. Sharanek A, Burban A, Burbank M, Le Guevel R, Li R, Guillouzo A, et al. Rho-kinase/myosin light chain kinase pathway plays a key role in the impairment of bile canaliculi dynamics induced by cholestatic drugs. Sci Rep. 2016;6:24709 pubmed 出版商
  7. Bell C, Hendriks D, Moro S, Ellis E, Walsh J, Renblom A, et al. Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease. Sci Rep. 2016;6:25187 pubmed 出版商
  8. Dröge C, Schaal H, Engelmann G, Wenning D, Haussinger D, Kubitz R. Exon-skipping and mRNA decay in human liver tissue: molecular consequences of pathogenic bile salt export pump mutations. Sci Rep. 2016;6:24827 pubmed 出版商
  9. Csandl M, Conseil G, Cole S. Cysteinyl Leukotriene Receptor 1/2 Antagonists Nonselectively Modulate Organic Anion Transport by Multidrug Resistance Proteins (MRP1-4). Drug Metab Dispos. 2016;44:857-66 pubmed 出版商
  10. Stindt S, Cebula P, Albrecht U, Keitel V, Schulte Am Esch J, Knoefel W, et al. Hepatitis C Virus Activates a Neuregulin-Driven Circuit to Modify Surface Expression of Growth Factor Receptors of the ErbB Family. PLoS ONE. 2016;11:e0148711 pubmed 出版商
  11. Liu X, Yue X, Chen S, Chen J, Li R. Significance of the expression of MRP1 and MRP2 in peripheral blood mononuclear cells of children with intractable epilepsy. Exp Ther Med. 2015;10:1784-1788 pubmed
  12. Fanelli M, Hattinger C, Vella S, Tavanti E, Michelacci F, Gudeman B, et al. Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in Osteosarcoma. Curr Cancer Drug Targets. 2016;16:261-74 pubmed
  13. Lou Y, Kanninen L, Kaehr B, Townson J, Niklander J, Harjumäki R, et al. Silica bioreplication preserves three-dimensional spheroid structures of human pluripotent stem cells and HepG2 cells. Sci Rep. 2015;5:13635 pubmed 出版商
  14. Bernd A, Ott M, Ishikawa H, Schroten H, Schwerk C, Fricker G. Characterization of efflux transport proteins of the human choroid plexus papilloma cell line HIBCPP, a functional in vitro model of the blood-cerebrospinal fluid barrier. Pharm Res. 2015;32:2973-82 pubmed 出版商
  15. Campia I, Buondonno I, Castella B, Rolando B, Kopecka J, Gazzano E, et al. An Autocrine Cytokine/JAK/STAT-Signaling Induces Kynurenine Synthesis in Multidrug Resistant Human Cancer Cells. PLoS ONE. 2015;10:e0126159 pubmed 出版商
  16. Barosso I, Zucchetti A, Miszczuk G, Boaglio A, Taborda D, Roma M, et al. EGFR participates downstream of ERα in estradiol-17β-D-glucuronide-induced impairment of Abcc2 function in isolated rat hepatocyte couplets. Arch Toxicol. 2016;90:891-903 pubmed 出版商
  17. Rigalli J, Ciriaci N, Arias A, Ceballos M, Villanueva S, Luquita M, et al. Regulation of multidrug resistance proteins by genistein in a hepatocarcinoma cell line: impact on sorafenib cytotoxicity. PLoS ONE. 2015;10:e0119502 pubmed 出版商
  18. Cermanova J, Kadova Z, Zagorova M, Hroch M, Tomsik P, Nachtigal P, et al. Boldine enhances bile production in rats via osmotic and farnesoid X receptor dependent mechanisms. Toxicol Appl Pharmacol. 2015;285:12-22 pubmed 出版商
  19. Somorácz A, Korompay A, Törzsök P, Patonai A, Erdélyi Belle B, Lotz G, et al. Tricellulin expression and its prognostic significance in primary liver carcinomas. Pathol Oncol Res. 2014;20:755-64 pubmed 出版商
  20. Guo S, Yu Y, Zhang N, Cui Y, Zhai L, Li H, et al. Higher level of plasma bioactive molecule sphingosine 1-phosphate in women is associated with estrogen. Biochim Biophys Acta. 2014;1841:836-46 pubmed 出版商
  21. Ramaiahgari S, den Braver M, Herpers B, Terpstra V, Commandeur J, van de Water B, et al. A 3D in vitro model of differentiated HepG2 cell spheroids with improved liver-like properties for repeated dose high-throughput toxicity studies. Arch Toxicol. 2014;88:1083-95 pubmed 出版商
  22. Gieseck R, Hannan N, Bort R, Hanley N, Drake R, Cameron G, et al. Maturation of induced pluripotent stem cell derived hepatocytes by 3D-culture. PLoS ONE. 2014;9:e86372 pubmed 出版商
  23. Huuskonen P, Myllynen P, Storvik M, Pasanen M. The effects of aflatoxin B1 on transporters and steroid metabolizing enzymes in JEG-3 cells. Toxicol Lett. 2013;218:200-6 pubmed 出版商
  24. Aleksunes L, Xu J, Lin E, Wen X, Goedken M, Slitt A. Pregnancy represses induction of efflux transporters in livers of type I diabetic mice. Pharm Res. 2013;30:2209-20 pubmed 出版商
  25. Rigalli J, Perdomo V, Luquita M, Villanueva S, Arias A, Theile D, et al. Regulation of biotransformation systems and ABC transporters by benznidazole in HepG2 cells: involvement of pregnane X-receptor. PLoS Negl Trop Dis. 2012;6:e1951 pubmed 出版商
  26. Rosales R, Monte M, Blazquez A, Briz O, Marin J. ABCC2 is involved in the hepatocyte perinuclear barrier for small organic compounds. Biochem Pharmacol. 2012;84:1651-9 pubmed 出版商
  27. Tchaparian E, Houghton J, Uyeda C, Grillo M, Jin L. Effect of culture time on the basal expression levels of drug transporters in sandwich-cultured primary rat hepatocytes. Drug Metab Dispos. 2011;39:2387-94 pubmed 出版商
  28. Haenisch S, Laechelt S, Bruckmueller H, Werk A, Noack A, Bruhn O, et al. Down-regulation of ATP-binding cassette C2 protein expression in HepG2 cells after rifampicin treatment is mediated by microRNA-379. Mol Pharmacol. 2011;80:314-20 pubmed 出版商
  29. Mason C, Buhimschi I, Buhimschi C, Dong Y, Weiner C, Swaan P. ATP-binding cassette transporter expression in human placenta as a function of pregnancy condition. Drug Metab Dispos. 2011;39:1000-7 pubmed 出版商